Ask AI
ProCE Banner Activity

Combating Myeloma: Improving Access and Outcomes With CAR T-Cell and Bispecific Antibody Therapies in Veterans With Relapsed/Refractory Multiple Myeloma

Slideset

Downloadable slideset on personalized approaches for the selection of CAR T-cell therapy and bispecific antibodies for patients with multiple myeloma.

Released: September 25, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Johnson & Johnson.

Bristol Myers Squibb

Johnson & Johnson